1,957 Shares in Astera Labs, Inc. $ALAB Bought by Visionary Wealth Advisors

Visionary Wealth Advisors bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, Holdings Channel reports. The fund bought 1,957 shares of the company’s stock, valued at approximately $945,000.

Other hedge funds also recently added to or reduced their stakes in the company. Glenmede Trust Co. NA grew its position in Astera Labs by 2.7% during the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after purchasing an additional 51 shares during the period. Keating Financial Advisory Services Inc. acquired a new position in shares of Astera Labs in the 2nd quarter valued at about $25,000. Lido Advisors LLC lifted its holdings in shares of Astera Labs by 0.5% in the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after buying an additional 57 shares during the period. Goldstein Advisors LLC lifted its holdings in shares of Astera Labs by 5.8% in the 4th quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock valued at $268,000 after buying an additional 88 shares during the period. Finally, Johnson Financial Group Inc. purchased a new stake in shares of Astera Labs in the second quarter worth about $43,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms recently commented on ALAB. UBS Group reaffirmed a “neutral” rating and set a $425.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. Evercore reissued an “outperform” rating and issued a $297.00 price target on shares of Astera Labs in a report on Tuesday, May 19th. Barclays upped their price objective on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research report on Monday, July 20th. Morgan Stanley raised their price objective on shares of Astera Labs to $335.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. Finally, TD Cowen cut their target price on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $333.00.

Astera Labs Stock Down 2.6%

Shares of Astera Labs stock opened at $277.53 on Tuesday. The firm has a market cap of $48.15 billion, a PE ratio of 137.39 and a beta of 3.84. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The business has a 50-day moving average price of $350.46 and a 200 day moving average price of $246.41.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. During the same quarter in the prior year, the business posted $0.44 earnings per share. Astera Labs’s revenue for the quarter was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current year.

Insider Buying and Selling at Astera Labs

In related news, Director Jack R. Lazar sold 10,000 shares of Astera Labs stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the sale, the director owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. This trade represents a 11.67% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the business’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total transaction of $4,047,300.00. Following the completion of the sale, the director directly owned 4,631 shares of the company’s stock, valued at approximately $2,083,950. The trade was a 66.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 419,244 shares of company stock worth $163,135,169. 10.40% of the stock is currently owned by corporate insiders.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.